Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 10.6B | 7.6B | 14.2B | 11.4B |
Cost of revenue | 2.9B | 2.3B | 4.1B | 3.4B |
Gross profit | 7.7B | 5.4B | 10.1B | 8.0B |
Operating expense | ||||
Research & development | 1.8B | 2.1B | 1.9B | 1.7B |
Selling general and admin | 2.2B | 1.2B | 2.7B | 2.7B |
Other operating expenses | 827M | 929M | 971M | 831M |
Operating income | 2.5B | 861M | 4.1B | 2.3B |
Non operating interest income | ||||
Income | 86M | -1M | 133M | 92M |
Expense | 213M | -102M | 265M | 135M |
Other income expense | -176M | -282M | -454M | -685M |
Pretax income | 2.2B | 456M | 3.5B | 1.4B |
Tax provision | 481M | 4M | 737M | 299M |
Net income | 1.9B | 511M | 2.8B | 1.1B |
Basic EPS | 1.5 | 0.5 | 2.3 | — |
Diluted EPS | 1.5 | 0.5 | 2.3 | — |
Basic average shares | 1.2B | 1.3B | 1.3B | — |
Diluted average shares | 1.2B | 1.3B | 1.3B | — |
EBITDA | 2.9B | 845M | 4.7B | 2.7B |
Net income from continuing op. | — | — | — | — |
Minority interests | -21M | -12M | -29M | -4M |
Preferred stock dividends | — | — | — | — |